Recombinant Human Relaxin in the Treatment of Scleroderma
Year: 2000
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Annals of Internal Medicine
Authors: James R. Seibold, Joseph H. Korn, Robert Simms, Phillip J. Clements, Larry W. Moreland, Maureen D. Mayes, Daniel E. Furst, Naomi Rothfield, Virginia Steen, Michael Weisman, David Collier, Fredrick M. Wigley, Peter A. Merkel, Mary Ellen Csuka, Vivien Hsu, Susan Rocco, Mark Erikson, John Hannigan, W. Scott Harkonen, Martin E. Sanders
Institutions: Boston University, Johns Hopkins University, University of California, Los Angeles, Wayne State University, Medical College of Wisconsin, Georgetown University Medical Center, Johns Hopkins Bayview Medical Center, University of Alabama at Birmingham, University of California San Diego, Massachusetts General Hospital, UConn Health, Georgetown University
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2117388663
